Previous 10 | Next 10 |
The NASDAQ Biotechnology Index (INDEXNASDAQ: NBI ) had a bit of a rocky week, but managed to stay in the green over the course of the trading period. The index opened last Monday (November 11) at 3,459.2 points before reaching 3,492.46 points as of 1:33 p.m. EST on Friday (November 15)...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks, and our single stock focus. If you are interested in listening to Stocks To Watch ...
Five IPOs and two SPACs plan to raise $634 million in the week ahead. One of the leading makers of cryptocurrency mining equipment, Canaan (CAN) plans to raise $100 million at a $1.6 billion market cap. It originally filed to raise $400 million (and in 2018 was rumored to be targeting over $...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
SOUTH SAN FRANCISCO, Calif. , Nov. 15, 2019 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announced that it will present data from an ongoing ...
Thinly traded micro cap IDEAYA Biosciences ( IDYA +44.1% ) is up on a 4x surge volume, albeit on turnover of only 163K shares, following its Q3 report . Highlights: More news on: IDEAYA Biosciences, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Re...
Gainers: Nortech Systems (NASDAQ: NSYS ) +98% . More news on: Nortech Systems Incorporated, FuelCell Energy, Inc., Cardlytics, Inc., Stocks on the move, Read more ...
IDEAYA Biosciences (NASDAQ: IDYA ): Q3 GAAP EPS of -$0.54 beats by $0.13 . More news on: IDEAYA Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
SOUTH SAN FRANCISCO, Calif. , Nov. 13, 2019 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics, provide...
SOUTH SAN FRANCISCO, Calif. , Nov. 5, 2019 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announced that Dr. Paul A. Barsanti , Ph.D., has joined ...
News, Short Squeeze, Breakout and More Instantly...
IDEAYA Biosciences Inc. Company Name:
IDYA Stock Symbol:
NASDAQ Market:
IDEAYA Biosciences Inc. Website:
IDEAYA Biosciences Announces Option and License Agreement for Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC Program with Biocytogen PR Newswire Option for an exclusive worldwide license for potential first-in class B7H3/PTK7 topo-I-payload bispecific antibod...
Biocytogen granted IDEAYA an option for an exclusive worldwide license for potential first-in-class B7H3/PTK7 topo-I-payload bispecific antibody drug conjugate (BsADC) program B7H3/PTK7 co-expression found in multiple solid tumor types, including double-digit percent prevalence in lung, color...
IDEAYA Biosciences to Participate in Upcoming August 2024 Investor Relations Event PR Newswire SOUTH SAN FRANCISCO, Calif. , July 29, 2024 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery an...